What's new

Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Date of authorisation: 19/11/2012, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Date of authorisation: 19/11/2012, Revision: 14, Status: Authorised

May 2, 2025 - 15:54
 0
Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Date of authorisation: 19/11/2012, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Date of authorisation: 19/11/2012, Revision: 14, Status: Authorised
Read More

Tags:

Previous Article

Southern California Edison likely faces ‘material losses’ from Eaton Fire, CEO says

Next Article

Human medicines European public assessment report (EPAR): Xeloda, capecitabine, ...

Related Posts

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Policies and procedures

Policies and procedures

Apr 22, 2025  0

Agenda of the HMPC meeting 5-7 May 2025

May 2, 2025  0